Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 83Breast Neoplasms 52Salivary Gland Neoplasms 3Prostate Adenocarcinoma 3Neoplasms 3Triple Negative Breast Neoplasms 2Recurrence 2Osteoporosis 2Neoplasm Metastasis 2Leiomyoma 2Breast Neoplasms, Male 2Advanced Breast Cancer 2Stage I Prostate Adenocarcinoma AJCC v7 1Sexual Dysfunctions, Psychological 1Sexual Dysfunction, Physiological 1Sarcopenia 1Radiation Injuries 1Primary Ovarian Insufficiency 1Primary Dysautonomias 1Patients With T1-4 Advanced Prostate Cancer 1Patient Compliance 1PSA Level Greater Than Two 1Ovarian Neoplasms 1Myofibroma 1Lymphatic Metastasis 1Kidney Diseases 1Hypertension 1Hyperlipidemias 1Hot Flashes 1Hormone-sensitive Metastatic Breast Cancer 1

Interventions

Letrozole 5pyrotinib 4Trastuzumab 4Anastrozole 4palbociclib 3exemestane 2abemaciclib 2Sodium Chloride 2Exercise 2Epirubicin 2Drug Evaluation 2Docetaxel 2Cyclophosphamide 2Botulinum Toxins, Type A 2Blood Specimen Collection 2Aromatase Inhibitors 2sacubitril and valsartan sodium hydrate drug combination 1ribociclib 1pertuzumab 1gadoterate meglumine 1Vinorelbine 1Tomography, X-Ray Computed 1Tamoxifen 1Surveys and Questionnaires 1Surgimend 1Surgical Procedures, Operative 1Paclitaxel 1Mammaplasty 1Liquid Biopsy 1Leflunomide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Breast Diseases × Goserelin × Clear all
NCT03373708 2017-12-18

Risk and Clinical Benefit of Chemotherapy and Intensive Endocrine Therapy for Luminal B1 Early-stage Breast Cancer

Shandong Cancer Hospital and Institute

Phase 2/3 Unknown
200 enrolled
Breast

Breast Diseases, Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡